ACE-inhibitor-induced cough, an adverse drug reaction unrecognised for several years: Studies in prescription-event monitoring

European Journal of Clinical Pharmacology

Volumn 49, Issue 6, 1996, Pages 431-437

  Kubota, K ^a   Kubota, N ^a   Pearce, G L ^a   Inman, W H W ^a  

^a DRUG SAFETY RESEARCH UNIT   (United Kingdom)

Author keywords

ACE inhibitor; Cough; Drug induced; Pharmacoepidemiology; Post marketing surveillance; Prescription event monitoring

Indexed keywords

AMLODIPINE; BETAXOLOL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; ISRADIPINE; LISINOPRIL; NICARDIPINE; PERINDOPRIL; RAMIPRIL; XAMOTEROL;

ADVERSE DRUG REACTION; ARTICLE; COUGHING; HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0029866037     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00195927     Document Type: Article

References (30)

1. Goldszer RC, Lilly LS, Solomon HS (1988) Prevalence of cough during angiotensin converting enzyme inhibitor therapy. Am J Med 85:887
2. Simon SR, Black HR, Moser M, Berland WE (1992) Cough and ACE inhibitors. Arch Intern Med 152:1698-1700
3. Ondetti MA, Rubin B, Cushman DW (1977) Design of specific inhibitors of angiotensin converting enzyme. New class of orally active antihypertensive agents. Science 196:441-444
4. Gavras H, Brunner HR, Turini GA, Kershaw GR, Tifft CP, Cuttelod S, Gavras I, Vukovich R A, McKinstry DN (1978) Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. N Engl J Med 298:991-995
5. Heel RC, Brogden RN, Speight TM, Avery GS (1980) Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. Drugs 20:409-452
6. Vidt DG, Bravo EL, Fouad FM (1982) Captopril. N Engl J Med 306:214-219
7. Havelka J, Vetter H, Studer A, Greminger P, Lüscher T, Wollnik S, Siegenthaler W, Vetter W (1982) Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension. Am J Cardiol 49:1467-1474
8. Havelka J, Boerlin HJ, Studer A, Greminger P, Tenschert W, Luescher T, Siegenthaler W, Vetter W, Walger P, Vetter H (1982) Long-term experience with captopril in severe hypertension. Br J Clin Pharmacol 14:718-765
9. Leier CV, Bambach D, Nelson S, Hermiller JB, Huss P, Magorien RD, Unverferth DV (1983) Captopril in primary pulmonary hypertension. Circulation 67:155-161
10. Hodsman GP, Robertson JIS (1983) Captopril: five years on. Br Med J 287:851-852
11. Frohlich ED, Cooper RA, Lewis EJ (1984) Review of the over-all experience of captopril in hypertension. Arch Intern Med 144.-1441-1444
12. McFate Smith W, Davies RO, Gabriel MA, Kramsch DM, Moncloa F, Rush JE, Walker JF (1984) Tolerance and safety of enalapril. Br J Clin Pharmacol 18:2498-2535
13. Edwards CRW, Padfield PL (1985) Angiotensin-converting enzyme inhibitors: past, present, and bright future. Lancet I:30-34
14. Riley LJ, Vlasses PH, Ferguson RK (1985) Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalapril. Am Heart J 109:1085-1089
15. Soseko S, Kaneko Y (1985) Cough associated with the use of captopril. Arch Intern Med 145:1524
16. Mitchell A, Gillies A, Carney S, Smith AJ (1986) Cough and captopril. Arch Intern Med 146:1017
17. Carruthers SG (1986) Severe coughing during captopril and enalapril therapy. Can Med Assoc J 135:217-218
18. Israel-Biet D, Delaisements C, Chretien J (1986) Enalapril-induced cough. Lancet 2:918
19. Sample PF, Herd GW (1986) Cough and wheeze caused by inhibitors of angiotensin-converting enzyme. N Engl J Med 314:61
20. Webb D, Benjamin N, Collier J, Robinson B (1986) Enalapril-induced cough. Lancet 2:1094
21. Inman WHW (1986) Enalapril-induced cough. Lancet 2:1218
22. Crombie A, Manson P, McVey D, Smith MW, Smeeton VJ, Somerton DT (1986) Once daily enalapril in general practice patients with mild to moderate essential hypertension. NZ Med J 99:503-504
23. DiBianco R (1986) Adverse reactions with angiotensin converting enzyme (ACE) inhibitors. Medical Toxicol 1:122-141
24. Todd PA, Heel RC (1986) Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs 31:198-248
25. Salena BJ (1986) Chronic cough and the use of captopril: unmasking asthma. Arch Intern Med 146:202-203
26. Irvin JD, Viau JM (1986) Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril. Am J Med 81 (Suppl 4C): 46-50
27. Coulter DM, Edwards IR (1987) Cough associated with captopril and enalapril. Br Med J 194:1521-1523
28. Inman WHW, Rawson NSB, Wilton LV, Pearce GL, Speirs CJ (1988) Postmarketing surveillance of enalapril. I: results of prescription-event monitoring. Br Med J 297:826-829
29. Inman WHW, Rawson NSB, Wilton LV (1985) Prescription-event monitoring. In: Inman W.H.W. (ed). Monitoring for drug safety, MTP press, Lancaster, England, pp 213-235
30. Rawson NSB, Pearce GL, Inman WHW (1990) Prescription-event monitoring: methodology and recent progress. J Clin Epidemiol 43:509-522